Results 1 to 10 of about 274,980 (287)
Journal of Pure and Applied Microbiology, 2023 The aim of this study was to examine the effectiveness and potential adverse reactions when providing a different Pfizer-BioNTech booster shot to 235 volunteers who had previously received the BBIBP-CorV Sinopharm primary vaccination series.
Nawfal R. Hussein +3 more
doaj +3 more sources
Рациональная фармакотерапия в кардиологии, 2019 Pfizer Company Press Release.
Company Pfizer
doaj +4 more sources
A case of Guillain–Barre syndrome following Pfizer COVID-19 vaccine
Journal of Community Hospital Internal Medicine Perspectives, 2021 Since the first-reported case of Severe Acute Respiratory Distress Syndrome-Coronavirus 2 in December 2019, COVID-19 has caused a global pandemic associated with significant morbidity and mortality.
Shiavax J Rao, Christopher J Haas
exaly +2 more sources
Current opinion in investigational drugs (London, England : 2000), 2005 Pfizer is developing lasofoxifene, an oral naphthalene derivative selective estrogen receptor modulator identified under a collaboration with Ligand, for the treatment of osteoporosis and vaginal atrophy. In August 2004, Pfizer submitted a New Drug Application to the Food and Drug Administration (FDA) seeking approval of lasofoxifene for the treatment ...
Gennari L.
openaire +3 more sources
Automated Measurement of Depigmentation Extent with a New AI Tool Applied to the Example of Vitiligo [PDF]
Dermatology and TherapyIntroduction We have developed a digital algorithm to assess skin pigmentation, specifically an artificial intelligence-based image analysis tool that segments photographed lesions and then scores them by Facial Vitiligo Area Scoring Index (F-VASI), in ...
Yalei Chen +9 more
doaj +2 more sources
Do Public Announcements of Drug Development Events Influence a Drug Company’s Market Value? A Study on Pfizer [PDF]
Journal of Library and Information Studies, 2022 The circulation of money in the global pharmaceutical market is substantial and has been increasing annually. Moreover, the high requirements for new drugs and the procedures for verifying the quality of drugs are increasingly complex; thus, successful ...
Yu-Han Tsao, Chun-Chieh Wang
doaj +1 more source
Biomedical and Biotechnology Research Journal, 2023 Background: Immunization against severe acute respiratory syndrome coronavirus 2 became necessary to control the menace of COVID-19. However, the safety of COVID-19 vaccines must be monitored continuously.
Mohan Bilikallahalli Sannathimmappa +5 more
doaj +1 more source
Biomedical and Biotechnology Research Journal, 2022 Background: Due to increased vaccination rates and the continued spread of the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus, many people are developing “hybrid immunity” to the virus.
Rawaq Taleb Hassan, Suhad Hadi Mohammed
doaj +1 more source
Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
Human Vaccines & Immunotherapeutics, 2021 The unprecedented need to acquire a safe and effective vaccine for the long-term control of coronavirus disease 2019 (COVID-19) is a global imperative. Researchers have been working urgently and collaboratively to develop vaccines against the causative ...
Khalid Hajissa, Ali Mussa
doaj +1 more source
A Case of Minimal Change Disease after SARS-CoV-2 Vaccination under the Age of 18
Avicenna Journal of Medicine, 2022 This is a care report of a 16-year-old-male who developed de novo minimal change disease following the second dose of the Pfizer vaccine. The patient developed sudden onset edema and 10 kg weight gain. He had nephrotic range proteinuria with normal renal
Mohamad Nour Alhosaini
doaj +1 more source